Cargando…

Detection of phenotype‐specific therapeutic vulnerabilities in breast cells using a CRISPR loss‐of‐function screen

Cellular phenotype plasticity between the epithelial and mesenchymal states has been linked to metastasis and heterogeneous responses to cancer therapy, and remains a challenge for the treatment of triple‐negative breast cancer (TNBC). Here, we used isogenic human breast epithelial cell lines, D492...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barkovskaya, Anna, Goodwin, Craig M., Seip, Kotryna, Hilmarsdottir, Bylgja, Pettersen, Solveig, Stalnecker, Clint, Engebraaten, Olav, Briem, Eirikur, Der, Channing J., Moestue, Siver A., Gudjonsson, Thorarinn, Mælandsmo, Gunhild M., Prasmickaite, Lina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8333781/ https://www.ncbi.nlm.nih.gov/pubmed/33759347 http://dx.doi.org/10.1002/1878-0261.12951

Ejemplares similares

O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes
por: Barkovskaya, Anna, et al.
Publicado: (2019)

Inhibition of PTP1B disrupts cell–cell adhesion and induces anoikis in breast epithelial cells
por: Hilmarsdottir, Bylgja, et al.
Publicado: (2017)

Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells
por: Barkovskaya, Anna, et al.
Publicado: (2020)

Functional Role of the microRNA-200 Family in Breast Morphogenesis and Neoplasia
por: Hilmarsdottir, Bylgja, et al.
Publicado: (2014)

Argininosuccinate lyase is a metabolic vulnerability in breast development and cancer
por: Karvelsson, Sigurdur Trausti, et al.
Publicado: (2021)

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors
por: Seip, Kotryna, et al.
Publicado: (2016)

Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer
por: Grinde, Maria T., et al.
Publicado: (2019)

Expression of ncRNAs on the DLK1-DIO3 Locus Is Associated With Basal and Mesenchymal Phenotype in Breast Epithelial Progenitor Cells
por: Budkova, Zuzana, et al.
Publicado: (2020)

Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models
por: Moestue, Siver A, et al.
Publicado: (2010)

Context-Dependent Function of Myoepithelial Cells in Breast Morphogenesis and Neoplasia
por: Ingthorsson, Saevar, et al.
Publicado: (2015)

Breast cancer patient-derived explant cultures recapitulate in vivo drug responses
por: Pettersen, Solveig, et al.
Publicado: (2023)

Expression and Functional Role of Sprouty-2 in Breast Morphogenesis
por: Sigurdsson, Valgardur, et al.
Publicado: (2013)

Epithelial Plasticity During Human Breast Morphogenesis and Cancer Progression
por: Ingthorsson, Saevar, et al.
Publicado: (2016)

Differential In Vivo Tumorigenicity of Distinct Subpopulations from a Luminal-Like Breast Cancer Xenograft
por: Skrbo, Nirma, et al.
Publicado: (2014)

AXL inhibition improves BRAF-targeted treatment in melanoma
por: Nyakas, Marta, et al.
Publicado: (2022)

Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer
por: Moestue, Siver A, et al.
Publicado: (2013)

Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma
por: Engesæter, Birgit, et al.
Publicado: (2012)

Interplay of choline metabolites and genes in patient-derived breast cancer xenografts
por: Grinde, Maria T, et al.
Publicado: (2014)

EGFR Signal-Network Reconstruction Demonstrates Metabolic Crosstalk in EMT
por: Choudhary, Kumari Sonal, et al.
Publicado: (2016)

Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model
por: Kim, Eugene, et al.
Publicado: (2016)

Basal‐like breast cancer engages tumor‐supportive macrophages via secreted factors induced by extracellular S100A4
por: Prasmickaite, Lina, et al.
Publicado: (2018)

HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR
por: Ingthorsson, S, et al.
Publicado: (2016)

Endothelial Induced EMT in Breast Epithelial Cells with Stem Cell Properties
por: Sigurdsson, Valgardur, et al.
Publicado: (2011)

Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft
por: Pandya, Abhilash D., et al.
Publicado: (2021)

Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism
por: Itkonen, Harri M., et al.
Publicado: (2016)

Intravascular Targets for Molecular Contrast-Enhanced Ultrasound Imaging
por: Moestue, Siver A., et al.
Publicado: (2012)

hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma
por: Fleten, Karianne G, et al.
Publicado: (2016)

Nuclear Legumain Activity in Colorectal Cancer
por: Haugen, Mads H., et al.
Publicado: (2013)

Correction: Nuclear Legumain Activity in Colorectal Cancer
por: Haugen, Mads H., et al.
Publicado: (2013)

Aldehyde Dehydrogenase (ALDH) Activity Does Not Select for Cells with Enhanced Aggressive Properties in Malignant Melanoma
por: Prasmickaite, Lina, et al.
Publicado: (2010)

Melanoma brain colonization involves the emergence of a brain-adaptive phenotype
por: Nygaard, Vigdis, et al.
Publicado: (2014)

High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer
por: Normann, Lisa Svartdal, et al.
Publicado: (2023)

R2* Relaxation Affects Pharmacokinetic Analysis of Dynamic Contrast-Enhanced MRI in Cancer and Underestimates Treatment Response at 7 T
por: Kim, Jana, et al.
Publicado: (2019)

VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in KRAS-mutant pancreatic cancer
por: Lee, Ye S., et al.
Publicado: (2023)

Ceramide-containing liposomes with doxorubicin: time and cell-dependent effect of C6 and C12 ceramide
por: Øverbye, Anders, et al.
Publicado: (2017)

Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy and Bevacizumab in HER2-Negative Breast Cancers
por: Haugen, Mads H., et al.
Publicado: (2021)

Timing, not magnitude, of force may explain sex-dependent risk of ACL injury
por: Sigurðsson, Haraldur B., et al.
Publicado: (2018)

The BRCA1 c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic BRCA1 Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows Homozygous Viability
por: Arason, Adalgeir, et al.
Publicado: (2019)

Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways
por: Amirfallah, Arsalan, et al.
Publicado: (2021)

Identification of Metastasis-Associated Metabolic Profiles of Tumors by (1)H-HR-MAS-MRS()()()
por: Gorad, Saurabh S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3g6i89e3edt8drna9af7u3696r